PS-341 in Treating Patients With Metastatic Kidney Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of PS-341 is more effective in treating metastatic kidney cancer. PURPOSE: Randomized phase III trial to study the effectiveness of PS-341 in treating patients who have metastatic kidney cancer.

Timeline

Start

2001-10

Primary completion

2002-09

Completion

2006-03

Drugs

Indications